Deerfield Private Design Fund III, L.P.'s Net Worth
$0
Who is Deerfield Private Design Fund III, L.P.?
Deerfield Private Design Fund III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fractyl Health, Inc., RHYTHM PHARMACEUTICALS, INC., XERIS PHARMACEUTICALS INC, REGENXBIO Inc., Editas Medicine, Inc., Shockwave Medical, Inc., AERIE PHARMACEUTICALS INC, ARVINAS INC., Neos Therapeutics, Inc., Avalanche Biotechnologies, Inc., GRAYBUG VISION, INC., Acutus Medical, Inc., Larimar Therapeutics, Inc., Syros Pharmaceuticals, Inc., CytomX Therapeutics, Inc., PROTEON THERAPEUTICS INC, AveXis, Inc., SteadyMed Ltd., aTYR PHARMA INC, LUMOS PHARMA, INC., ALIMERA SCIENCES INC, Homology Medicines, Inc., Oncorus, Inc., Audentes Therapeutics, Inc., and ARS Pharmaceuticals, Inc..
SEC CIK
Deerfield Private Design Fund III, L.P.'s CIK is 0001603333
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fractyl Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 834.25K |
—
|
—
| 834.25K |
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 937.01K |
$17.00 |
—
| 937.01K |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XERIS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.84% | -7.24K |
$15.09 | -$109,250.53 | 856.47K |
Feb 8 - Feb 11
| |||
Form 4
| -1.69% | -14.81K |
$15.02 | -$222,442.86 | 863.71K |
Feb 5 - Feb 7
| |||
Form 4
| -0.79% | -7.04K |
$15.12 | -$106,448.09 | 878.52K |
Jan 28 - Jan 29
| |||
Form 4
| -11.44% | -114.44K |
$15.43 | -$1,766,192.63 | 885.56K |
Jan 23 - Jan 25
| |||
Form 4
|
∞
| 2.5M |
$15.00 |
—
| 2.5M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REGENXBIO Inc. (RGNX) Snapshot price: $11.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.34M |
$22.00 | $1,925,000.00 | 1.34M |
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.81M |
$16.00 |
—
| 1.81M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||